{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:55:33Z","timestamp":1786992933673,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CC2129"],"award-info":[{"award-number":["CC2129"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["75\/OSI\/PA"],"award-info":[{"award-number":["75\/OSI\/PA"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220318\/A\/20\/Z"],"award-info":[{"award-number":["220318\/A\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jmb.2025.169062","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:28:11Z","timestamp":1741030091000},"page":"169062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Structural Plasticity of Plasmodium falciparum Plasmepsin X to Accommodate Binding of Potent Macrocyclic Hydroxyethylamine Inhibitors"],"prefix":"10.1016","volume":"437","author":[{"given":"Chrislaine","family":"Withers-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"Ogrodowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Kunzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Purkiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svend","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadims","family":"Kovada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigars","family":"Jirgensons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Blackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2025.169062_b0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (Mosquirix): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jmb.2025.169062_b0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2025.169062_b0015","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.257345","article-title":"Malaria parasite egress at a glance","volume":"134","author":"Tan","year":"2021","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jmb.2025.169062_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-micro-041320-020659","article-title":"Plasmodium egress across the parasite life cycle","volume":"76","author":"Dvorin","year":"2022","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.jmb.2025.169062_b0025","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1021\/acs.jmedchem.2c01093","article-title":"Subtilisin-like Serine Protease 1 (SUB1) as an emerging antimalarial drug target: current achievements in inhibitor discovery","volume":"65","author":"Lidumniece","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2025.169062_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.602803","article-title":"Targeting the malaria parasite cGMP-dependent protein kinase to develop new drugs","volume":"11","author":"Baker","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jmb.2025.169062_b0035","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1074\/jbc.REV120.009309","article-title":"Malaria parasite plasmepsins: more than just plain old degradative pepsins","volume":"295","author":"Nasamu","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"358","key":"10.1016\/j.jmb.2025.169062_b0040","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.aan1478","article-title":"Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion","volume":"27","author":"Nasamu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jmb.2025.169062_b0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1126\/science.aaf8675","article-title":"A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress","volume":"358","author":"Pino","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jmb.2025.169062_b0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.str.2022.03.018","article-title":"Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax","volume":"30","author":"Hodder","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2025.169062_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00673-23","article-title":"Activation of the plasmodium egress effector subtilisin-like protease 1 is mediated by plasmepsin X destruction of the prodomain","volume":"14","author":"Mukherjee","year":"2023","journal-title":"MBio"},{"key":"10.1016\/j.jmb.2025.169062_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130665","article-title":"The malaria parasite egress protease SUB1 is activated through precise, plasmepsin X-mediated cleavage of the SUB1 prodomain","volume":"1868","author":"Withers-Martinez","year":"2024","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jmb.2025.169062_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41564-018-0111-0","article-title":"A protease cascade regulates release of the human malaria parasite Plasmodium falciparum from host red blood cells","volume":"3","author":"Thomas","year":"2018","journal-title":"Nature Microbiol."},{"key":"10.1016\/j.jmb.2025.169062_b0070","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107226","article-title":"Autocatalytic activation of a malarial egress protease is druggable and requires a protein cofactor","volume":"40","author":"Tan","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.jmb.2025.169062_b0075","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.chom.2020.02.005","article-title":"Dual plasmepsin-targeting antimalarial agents disrupt multiple stages of the malaria parasite life cycle","volume":"27","author":"Favuzza","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jmb.2025.169062_b0080","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bmcl.2012.11.118","article-title":"Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold","volume":"23","author":"Ciana","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmb.2025.169062_b0085","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1021\/acsmedchemlett.2c00355","article-title":"The invention of WM382, a highly potent PMIX\/X dual inhibitor toward the treatment of malaria","volume":"13","author":"de Lera","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jmb.2025.169062_b0090","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1039\/C5OB01842K","article-title":"Synthesis of amino heterocycle aspartyl protease inhibitors","volume":"14","author":"Chambers","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jmb.2025.169062_b0095","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1021\/acs.jmedchem.2c01336","article-title":"Discovery and characterization of potent, efficacious, orally available antimalarial plasmepsin X inhibitors and preclinical safety assessment of UCB7362","volume":"65","author":"Lowe","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2025.169062_b0100","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1021\/acs.jmedchem.3c00812","article-title":"Macrocyclic peptidomimetic plasmepsin X inhibitors with potent in vitro and in vivo antimalarial activity","volume":"66","author":"Kovada","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2025.169062_b0105","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/pro.4279","article-title":"Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme","volume":"31","author":"Kesari","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmb.2025.169062_b0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/toxres\/tfaa106","article-title":"A target safety assessment of the potential toxicological risks of targeting plasmepsin IX\/X for the treatment of malaria","volume":"10","author":"Barber","year":"2021","journal-title":"Toxicol. Res. (Camb)"},{"key":"10.1016\/j.jmb.2025.169062_b0115","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1039\/D2RA06246A","article-title":"Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D","volume":"13","author":"Martins","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmb.2025.169062_b0120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejmech.2018.11.068","article-title":"Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D","volume":"163","author":"Zogota","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmb.2025.169062_b0125","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1006\/jmbi.1994.1052","article-title":"Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins","volume":"235","author":"Abagyan","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2025.169062_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1107\/S2059798317017235","article-title":"DIALS: implementation and evaluation of a new integration package","volume":"74","author":"Winter","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.jmb.2025.169062_b0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","author":"Evans","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2025.169062_b0140","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2025.169062_b0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/j.jmb.2025.169062_b0150","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1107\/S2059798323002413","article-title":"GEMMI and Servalcat restrain REFMAC5","volume":"79","author":"Yamashita","year":"2023","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.jmb.2025.169062_b0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2025.169062_b0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T15:20:58Z","timestamp":1743866458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283625001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0022283625001287"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169062","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural Plasticity of Plasmodium falciparum Plasmepsin X to Accommodate Binding of Potent Macrocyclic Hydroxyethylamine Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"169062"}}